Hybrid PEEK-Acrylic Resin Prostheses and the All-on-4 Concept for Full-Arch Rehabilitation - Routine Group (AO4PEEKRG)

October 18, 2022 updated by: Malo Clinic

Hybrid Polyetheretherketone (PEEK)-Acrylic Resin Prostheses and the All-on-4 Concept for Full-Arch Rehabilitation - Routine Group

The goal of this observational study is to evaluate the outcome of a Poly-ether-ether-ketone - acrylic resin prosthesis for full-arch rehabilitation of the atrophic maxillae through the All-on-4 concept after five years of follow-up. The main question it aims to answer is:

- What is the survival outcome of the full-arch implant-supported Poly-ether-ether-ketone - acrylic resin prosthesis? The participants already rehabilitated with dental implants will receive a Poly-ether-ehter-ketone prosthesis as a definitive prosthesis.

Study Overview

Detailed Description

Following the learning generated during a development study with implant supported fixed prostheses using polyetheretherketone (PEEK) material, it is necessary to evaluate the outcome of implant supported fixed prosthetic rehabilitations using PEEK material in a routine scenario, following optimized laboratory and treatment protocol.

The study design will be a prospective single cohort to evaluate the long term outcome of fixed prosthetic implant supported rehabilitations. The cohort will be evaluated at 6 months, 12 months and annually thereafter until 5 years of follow-up. At each follow-up assessments multiple evaluaitons will be performed to assess the overall outcome of the restorations.

Study Type

Interventional

Enrollment (Actual)

39

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lisbon, Portugal, 1600-042
        • Malo Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients rehabilitated with immediate function implants for complete edentulous arches through the All-on-4 Concept.
  • Patients in need of definitive implant-supported restorations.
  • Written informed consent from each patient to participate in the study.

Exclusion Criteria:

- Hindrance to provide written informed consent. (A patient cannot participate if no written consent is given)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: All-on-4 PEEK routine
Prosthetic full-arch rehabilitation using a PEEK-acrylic resin prosthesis
A prosthetic full-arch rehabilitation of atrophic maxillae using a PEEk-acrylic resin prosthesis supported by dental implants following the All-on-4 Concept arrangement.
Other Names:
  • PEEK prosthesis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Survival of the prosthesis
Time Frame: 5 years
Evaluation of the survival for the PEEK-acrylic resin implant-supported prosthesis; nominal (survival,failure)
5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Survival of the implants
Time Frame: 5 years
Evaluation of the survival for implants supporting the PEEK-acrylic resin implant-supported prosthesis; nominal (survival,failure)
5 years
Incidence of biological complications
Time Frame: 5 years
Peri-implant infection, abscess, fistulae, suppuration, sinus infection, gingival dehiscence; Nominal (no incidence, incidence)
5 years
Incidence of mechanical complications
Time Frame: 5 years
Loosening or fracture of prosthetic components; Nominal (no incidence, incidence)
5 years
Marginal bone resorption
Time Frame: 5 years
Measured through periapical radiographs, in mm between the implant shoulder and the most apical portion of implant-bone contact; Scale
5 years
Denture staining
Time Frame: 5 years
Veneer discoloration or staining. If JUVORA is exposed same discoloration or staining 0:heavily stained; 10: no stains
5 years
In mouth comfort
Time Frame: 5 years
Visual analogue scale (0-10 cm); 0:very poor; 10: very good
5 years
Overall chewing feeling
Time Frame: 5 years
Visual analogue scale (0-10 cm); 0:very poor; 10: very good
5 years
Oral Health Impact Profile OHIP-14
Time Frame: 5 years
Likert Scale (0=least impact/never, 4=highest impact/very often)
5 years
Patient tissue reaction
Time Frame: 5 years
Visual analogue scale (0-10 cm); 0:very poor; 10: very good
5 years
Framework integrity
Time Frame: 5 years
Visual analogue scale (0-10 cm); 0:very poor; 10: very good
5 years
Veneer adhesion
Time Frame: 5 years
Visual analogue scale (0-10 cm); 0:very poor; 10: very good
5 years
Manufacture issues
Time Frame: 5 years
Visual analogue scale (0-10 cm); 0:very poor; 10: very good
5 years
Handling of material compared to metal
Time Frame: 5 years
Visual analogue scale (0-10 cm); 0:very poor; 10: very good
5 years
Aesthetics
Time Frame: 5 years
Visual analogue scale (0-10 cm); 0:very poor; 10: very good
5 years
Speech
Time Frame: 5 years
Visual analogue scale (0-10 cm); 0:very poor; 10: very good
5 years
Fit
Time Frame: 5 years
Visual analogue scale (0-10 cm); 0:very poor; 10: very good
5 years
Hygiene around the implants
Time Frame: 5 years
Visual analogue scale (0-10 cm); 0:very poor; 10: very good
5 years
Hygiene - how much plaque/calculus adheres to the prosthesis
Time Frame: 5 years
Visual analogue scale (0-10 cm); 0:very poor; 10: very good
5 years
Overall classification from KOL
Time Frame: 5 years
Visual analogue scale (0-10 cm); 0:very poor; 10: very good
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Miguel A de Araújo Nobre, PhD, Director of Research, Development and Education

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 13, 2017

Primary Completion (Actual)

April 1, 2021

Study Completion (Anticipated)

July 1, 2026

Study Registration Dates

First Submitted

October 18, 2022

First Submitted That Met QC Criteria

October 18, 2022

First Posted (Actual)

October 21, 2022

Study Record Updates

Last Update Posted (Actual)

October 21, 2022

Last Update Submitted That Met QC Criteria

October 18, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • AO4PEEKRoutGroup

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Anonymized database containing the study variables

IPD Sharing Time Frame

Upon study completion and for 8 years.

IPD Sharing Access Criteria

Upon solicitation to the Investigators

IPD Sharing Supporting Information Type

  • Statistical Analysis Plan (SAP)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prosthesis Survival

Clinical Trials on Prosthetic full-arch rehabilitation using a PEEK-acrylic resin prosthesis

3
Subscribe